IMARC Group

Although the bulk of the total demand is expected to come from the “Rashtriya Swasthaya Bima Yojna” (RSBY), we expect a number of private and government health insurance providers to adopt smart card technology in the short and medium terms.

Mobile advertising has evolved significantly in terms of creativity that allows consumers to watch video advertisements, get a 360 degrees view of a product, locate a store, and place the order by just using one single device.

This research study serves as an analytical as well as a statistical tool to understand not only the market trends, applications, structure, drivers, restraints, feedstocks and competitive landscape but also the outlook of the market till 2017.

As a result of the governments phase-wise digitization programme, the demand of smart cards in the Pay TV sector is expected to increase robustly in India.

Even though larger spends are taking place in metros and bigger towns, proposed massive infrastructure developments in Tier II and Tier III cities is expected to create huge opportunities for the advertising industry in these cities as well.

A new report expects the Indian insulin market to grow at a CAGR of 19% during 2013-2018.

IMARC Group is inviting requests for proposal to outsource its market research activities to companies having a strong domain expertise in the chemical industry and a local presence in China or Latin America.

During 2013-2018, we expect smart cards to further percolate into a number of other sectors such as credit/debit cards, financial inclusion, public distribution, healthcare, identity management, transportation, etc.

Despite strong historical growth, fertilizer consumption in India remains highly skewed. There are currently a number of states in India which still have a very low penetration of fertilizers. This leaves a lot of room for future growth.

The biotechnology market is undergoing a number of transformations. These include a shift of growth towards emerging markets, increasing focus on monoclonal antibodies and an increasing penetration of biosimilars.